Related Articles
BCR-ABL- and Ras-independent activation of Raf as a novel mechanism of Imatinib resistance in CML
Homoharringtonine enhances the effect of imatinib on chronic myelogenous leukemia cells by downregulating ZFX
Homoharringtonine promotes BCR‑ABL degradation through the p62‑mediated autophagy pathway
Proteomic analysis of imatinib-resistant CML-T1 cells reveals calcium homeostasis as a potential therapeutic target
Idelalisib induces G1 arrest and apoptosis in chronic myeloid leukemia K562 cells